Zeronda Tyler — SEC insider filings

SEC reporting owner CIK 1867033. 30 insider filings on record with FilingPulse; latest filed 2026-10-30.

Transaction summary — filings shown

Covers all 30 filings on record, filed 2021-07-02 to 2026-10-30. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
Yarrow Bioscience, Inc. (YARW)Chief Financial Officer30——35

Insider filings — Zeronda Tyler

FiledFormIssuerReported transactionsSource
2026-10-304Yarrow Bioscience, Inc. (YARW)Grant/award (A): 156,115 (derivative) @ $0EDGAR
2026-07-294Yarrow Bioscience, Inc. (YARW)Grant/award (A): 185,798 (derivative) @ $0EDGAR
2026-07-244VYNE Therapeutics Inc. (VYNE)Tax withholding (F): 22,516 @ $0.90EDGAR
2026-07-024VYNE Therapeutics Inc. (VYNE)Tax withholding (F): 3,464 @ $0.65EDGAR
2026-04-024VYNE Therapeutics Inc. (VYNE)Tax withholding (F): 4,007 @ $0.60EDGAR
2026-01-054VYNE Therapeutics Inc. (VYNE)Tax withholding (F): 7,858 @ $0.58EDGAR
2025-10-024VYNE Therapeutics Inc. (VYNE)Tax withholding (F): 3,420 @ $0.34EDGAR
2025-07-024VYNE Therapeutics Inc. (VYNE)Tax withholding (F): 3,420 @ $1.65EDGAR
2025-04-024VYNE Therapeutics Inc. (VYNE)Tax withholding (F): 8,399 @ $1.58EDGAR
2025-01-234VYNE Therapeutics Inc. (VYNE)Grant/award (A): 230,000 (derivative) @ $0EDGAR
2025-01-024VYNE Therapeutics Inc. (VYNE)Tax withholding (F): 4,675 @ $3.35EDGAR
2024-10-024VYNE Therapeutics Inc. (VYNE)Tax withholding (F): 84 @ $1.88EDGAR
2024-07-034VYNE Therapeutics Inc. (VYNE)Tax withholding (F): 92 @ $1.92EDGAR
2024-04-034VYNE Therapeutics Inc. (VYNE)Tax withholding (F): 94 @ $3.08EDGAR
2024-01-034VYNE Therapeutics Inc. (VYNE)Grant/award (A): 62,500 @ $0 · Tax withholding (F): 93 @ $2.28 · Grant/award (A): 62,500 (derivative) @ $0EDGAR
2023-12-154VYNE Therapeutics Inc. (VYNE)Grant/award (A): 62,500 @ $0 · Grant/award (A): 62,500 (derivative) @ $0EDGAR
2023-10-044VYNE Therapeutics Inc. (VYNE)Tax withholding (F): 1,087 @ $3.83EDGAR
2023-07-054VYNE Therapeutics Inc. (VYNE)Tax withholding (F): 91 @ $4.10EDGAR
2023-04-044VYNE Therapeutics Inc. (VYNE)Tax withholding (F): 384 @ $3.08EDGAR
2023-01-044VYNE Therapeutics Inc. (VYNE)Tax withholding (F): 354 @ $0.15EDGAR
2022-10-044VYNE Therapeutics Inc. (VYNE)Tax withholding (F): 353 @ $0.22EDGAR
2022-07-054VYNE Therapeutics Inc. (VYNE)Tax withholding (F): 354 @ $0.39EDGAR
2022-06-024VYNE Therapeutics Inc. (VYNE)Grant/award (A): 12,510 @ $0.35EDGAR
2022-04-044VYNE Therapeutics Inc. (VYNE)Tax withholding (F): 773 @ $0.65EDGAR
2022-03-184VYNE Therapeutics Inc. (VYNE)Grant/award (A): 75,000 @ $0 · Grant/award (A): 75,000 (derivative) @ $0EDGAR
2022-01-044VYNE Therapeutics Inc. (VYNE)Tax withholding (F): 206 @ $1.02EDGAR
2021-12-024VYNE Therapeutics Inc. (VYNE)Grant/award (A): 4,187 @ $0.88EDGAR
2021-10-014VYNE Therapeutics Inc. (VYNE)Tax withholding (F): 206 @ $1.39EDGAR
2021-09-034VYNE Therapeutics Inc. (VYNE)Grant/award (A): 60,859 @ $0 · Grant/award (A): 60,860 (derivative) @ $0EDGAR
2021-07-024VYNE Therapeutics Inc. (VYNE)Tax withholding (F): 700 @ $3.51EDGAR

FilingPulse's Form 4 archive currently extends back to 2021-07-02 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1867033 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs